2020 IAB Companies and Representatives
Agilent Technologies Inc. is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Representatives: Steve Fischer
Bruker provides innovative mass spectrometry systems for proteomics that overcome long-standing limitations in speed, sensitivity and robustness. We offer a complete range of proteomics solutions to enhance analytical depth and throughput and to minimize maintenance and downtime.
Representatives: Gary Kruppa, Pierre-Olivier Schmit
Bioinformatics Solutions Inc. (BSI) is a highly established company well-known for its PEAKS software and service platforms for proteomics discovery and therapeutic protein characterization by LC-MS. Its benchmark de novo sequencing capabilities, now advanced by deep learning, offers advanced solutions for proteomic and therapeutic protein discovery as provided through peptide/protein identification & quantification, peptide mapping, PTMs and sequence variants.
Representatives: Katherine Tran, Baozhen (Paul) Shan
Cambridge Isotope Laboratories, Inc. (CIL) is the world leader in the manufacturer of stable isotopes (e.g.,13C, D, 15N) and their compounds for an array of qualitative/quantitative research applications ranging from analytical chemistry to modern diagnostics. Proteomic products include peptide synthesis and protein expression starting materials, SILAC and SILAM reagents/kits, QC and quantitation kits, chemical tagging reagents, and enzymatic labeling reagents. CIL also offers an array of standards and mixes/kits for use in other MS ‘omics research (e.g., metabolomics, glycomics).
Representatives: Joel Louette, Andrew Percy
Founded by research scientists, Cell Signaling Technology (CST) is focused on proteomic discovery especially in the cancer field. Our products and services support your proteomics research and because we believe you have the right to expect more reliable results, our scientists produce, validate and support all our antibodies in-house.
Representatives: Kimberly Lee, Joshua Nathan
EVOSEP aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. Making sample preparation and separation before MS analysis 10 times faster and 100 times more robust will enable truly large cohort studies for biomarker validation and provide the foundation for precision medicine.
Representatives: Michael Andersen, Nicolai Bache
Fluidigm develops, manufactures, and markets research products for life science analytical and preparatory systems for use in mass cytometry, high-throughput genomics, and single cell genomics applications. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.
Representatives: Alexander Cherkassky, Andrew Quong
IonOpticks is revolutionising chromatography with robust and highly reproducible nanoflow columns that are leading the market in spray stability and depth of sample characterisation. Our plug and play zero dead volume packed emitter technology is setting a new standard, achieving over 25% more protein identifications than any other product on the market.
Representatives: Selima Webb, Jarrod Sandow
Newomics Inc. is a commercial stage biotechnology company in the San Francisco bay area. It is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. Its products include silicon-based multinozzle emitters (M3 emitters) and microfluidic LC-MS chips (MEA chips) that significantly increase the sensitivity and robustness of mass spectrometry.
Representatives: Daojing Wang, Na Parra
Olink offers unmatched high-multiplex analysis of actionable biomarkers within the human plasma proteome. We provide quantifiable results from minimal sample volume, with high throughput and exceptional sensitivity and specificity. Our mission is to accelerate proteomics together with the scientific community, enabling new discoveries and a better understanding of complex real-time human biology. We are committed to expand our protein library, providing coverage across a growing number of biological processes and pathways.
Representatives: Ida Grundberg, Eva Walde
Pelago Bioscience was founded in 2013 with the aim to maximize the awareness and use of our patented Cellular Thermal Shift Assay (CETSA®). Using CETSA we deliver in situ target engagement studies to accelerate preclinical and clinical drug discovery and diagnostics development. Our scientific team are the experts in both targeted (Classics & HT) and unbiased proteomics CETSA applications (CETSA MS/Thermal Proteome Profiling).
Representatives: Daniel Martinez Molina, Johan Lengqvist
ProtiFi, LLC provides innovative solutions for omics analyses from sample preparation trough to data analysis and is a spin out of Cold Spring Harbor Laboratory. The S-Trap, our sample extraction, concentration and cleaning system, has revolutionized our ability to obtain MS ready samples in record time regardless of sample or skill level. Tryp-N, “N-terminal trypsin,” gives complementary data to increase sequence coverage and certainty of identification. Finally, Simplifi makes it easy and simple to go from huge omics datasets to meaning and understanding of biology.
Representatives: John Wilson, Darryl Pappin
SCIEX solutions for biomarker & omics research enable scientists to push the limits in discovery proteomics, targeted peptide quantitation, lipidomics, metabolomics, protein characterization, and tissue imaging.
Representatives: Arianna Jones, Tom Knapman
Seer develops innovative solutions that act as a gateway to the proteome. Our products are designed to accelerate the pace of proteomics by removing the technological barriers that stand between you and the proteomics you want to do. The Proteograph platform enables unbiased, deep, rapid, large-scale proteomics studies – the kind needed to advance our understanding of biology, health, and disease. Our goal is to empower the scientific community with tools for exceptional proteomics outcomes.
Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. KREX was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge.
Representatives: Jonathan Blackburn, Bermet Abylova
SomaLogic seeks to deliver meaningful and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from the precise, proprietary, and personalized measurement of health-related changes in an individual’s proteins over time.
Representatives: Sheri Wilcox
Target Discovery, Inc. (TDI) provides analytical testing services, test support and packaged testing solutions to the clinical, veterinary, pharmaceutical, food, environmental, agriscience and consumer products industries. TDI uses advanced technology and innovative solutions to deliver affordable testing options that meet the specific needs of each client. We specialize in developing lightning fast, high performance tests powered by the selectivity of mass spectrometry and advanced data analysis strategies.
Representatives: Jeff Peterson, Mark Duncan
Thermo Scientific is the leading source of innovative, comprehensive workflow solutions to address the most challenging aspects of proteomics research.
Representatives: Julian Saba, Daniel Lopez-Ferrer
From biomarker discovery and translational research through to clinical diagnostic solutions, at Waters, we strive to improve human health by partnering with the biomedical community to help make breakthrough scientific discoveries and translate them into healthcare solutions.
Representatives: David Heywood, Roy Martin